Prospective clinical study of Jintiange capsule in the treatment of osteosarcopenia

The Third Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Women with menopause = 1 year, and men = 60 years old; can cooperate with basic data collection, bone mineral density examination, body composition analysis and serological testing; voluntarily participate in this study and sign the informed consent. 2. Meet the diagnostic criteria for osteoporosis; 3. Meet the diagnostic criteria for sarcopenia 4. Meet the diagnostic criteria for TCM diagnosis of kidney deficiency syndrome.

•Patients with serious cardiovascular, cerebrovascular, liver, kidney and other important organ diseases; patients with major diseases of the respiratory, digestive tract, urinary and other systems; patients with diseases affecting bone density and calcium and phosphorus metabolism; patients with malignant tumors; recent use Patients with drugs that affect bone metabolism and body composition; those who are too obese to undergo bone mineral density examination and body composition analysis; women who have undergone oophorectomy or total hysterectomy before menopause; suffer from neurological disorders that cause insight Those who lack; those who are illiterate and unable to answer lifestyle questionnaires and quality of life assessments; have participated in other academic researchers, etc.

发起方

The Third Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine